TCM Biotech International Corp. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 354.644 million compared to TWD 405.282 million a year ago. Operating income was TWD 700,000 compared to TWD 49.361 million a year ago. Net income was TWD 6.906 million compared to TWD 37.716 million a year ago. Basic earnings per share was TWD 0.15 compared to TWD 0.8 a year ago.